Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: T-cell large granular lymphocyte leukemia

PROVIDER: PRJNA919192 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23012639_1.fastq.gz	Fastqsanger.gz
	SRR23012639_2.fastq.gz	Fastqsanger.gz
	SRR23012640_1.fastq.gz	Fastqsanger.gz
	SRR23012640_2.fastq.gz	Fastqsanger.gz
	SRR23012641_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 88

Similar Datasets

Analysis of extracellular vesicles from large granular lymphocytic leukemia cell lines

Project description:Large granular lymphocyte leukemia (LGLL) is a rare lymphoproliferative malignancy caused by clonal expansion of granular lymphocytes. Two subgroups, (cytotoxic) T-cell LGLL and natural killer (NK) cell LGLL, are defined based on their cellular origin and expression of characteristic surface molecules. In this study, we performed a comparative proteome profiling of isolated extracellular vesicles (EV) from the T-LGLL cell line MOTN-1 and the NK-LGLL line NKL.

2024-10-17 | PXD053228 | Pride

Homo sapiens

Project description:Large Granular Lymphocyte Leukemia Mesenchymal Stem Cells

| PRJNA160169 | ENA

Homo sapiens

Project description:Expression data from patients with large granular lymphocyte leukemia

| PRJNA171833 | ENA

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Project description:This study uses a drug called dasatinib to produce an anti-cancer effect called large granular lymphocyte cellular expansion. Large granular lymphocytes are blood cells known as natural killer cells that remove cancer cells. Researchers think that dasatinib may cause large granular lymphocyte expansion to happen in patients who have received a blood stem cell transplant (SCT) between 3 to 15 months after the SCT. In this research study, researchers want to find how well dasatinib can be tolerated, the best dose to take of dasatinib and how to estimate how often large granular lymphocytic cellular expansion happens at the best dose of dasatinib.

| 2128801 | ecrin-mdr-crc

Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma

Project description:This study uses a drug called dasatinib to produce an anti-cancer effect called large granular lymphocyte cellular expansion. Large granular lymphocytes are blood cells known as natural killer cells that remove cancer cells. Researchers think that dasatinib may cause large granular lymphocyte expansion to happen in patients who have received a blood stem cell transplant (SCT) between 3 to 15 months after the blood SCT. In this research study, researchers want to find how well dasatinib can be tolerated, the best dose to take of dasatinib and to estimate how often large granular lymphocytic cellular expansion happens at the best dose of dasatinib.

| 2126216 | ecrin-mdr-crc

Molecular profiling of LGL leukemia reveals role of sphingolipid signaling of cytotoxic lymphocytes

Project description:We used microarrays to expression profile peripheral blood mononuclear cells (PBMCs) from LGL leukemia patients and control subjects to identify survival pathways that render leukemic LGL resistant to activation induced cell death. Keywords: granular lymphocyte leukemia, PBMC

2008-05-01 | GSE10631 | GEO

Large Granular Lymphocyte Leukemia Mesenchymal Stem Cells

Project description:The bone marrow microenvironment in Large Granular Lymphocyte Leukemia (LGLL) patients has been unexplored for it’s role in the development of cytopenias, which lead to complications resulting in the most prominent causes of morbidity and mortality. We used microarrays on primary mesenchymal stem cell (MSC) cultures isolated from bone marrow aspirates from LGLL patients to identify genetic programs that may lead to the observed profibrotic and extrinsically senescent phenotype.

2013-04-20 | GSE37470 | GEO

Homo sapiens

Project description:ECOG 5998, trial of immunosupressives for the treatment of Large Granular Lymphocyte Leukemia

| PRJNA182551 | ENA

Homo sapiens

Project description:A Phase 2 Study of R115777 in Large Granular Lymphocyte (LGL) Leukemia - BMFC 5402

| PRJNA188343 | ENA

Homo sapiens

Project description:A Phase 2 Study of R115777 in Large Granular Lymphocyte (LGL) Leukemia - BMFC 5402

| PRJNA188342 | ENA